+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type (Pharmaceutical, Biotechnology), By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030- Product Image
Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type (Pharmaceutical, Biotechnology), By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type (Pharmaceutical, Biotechnology), By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • March 2025
  • Region: Global
  • Grand View Research
  • ID: 5967398
Description Jump to:
The global small molecule innovator API CDMO market size is expected to reach USD 47.14 billion by 2030, registering a CAGR of 6.38% from 2025 to 2030. A growing outsourcing trend among pharmaceutical companies, increasing demand for small molecule drugs, and a surge in the number of clinical trials are anticipated to influence the market positively. The growing utilization of CDMOs in the pharmaceutical sector stems from various reasons, with cost-effectiveness as the prominent factor. Outsourcing emerges as an efficient strategy for pharmaceutical firms to reduce expenses by sidestepping the necessity for costly infrastructure and equipment investments. CDMOs offer the requisite expertise and infrastructure to deliver drug development and manufacturing services in a financially prudent manner.

Furthermore, enhanced efficiency serves as another pivotal driver for pharmaceutical outsourcing. With mounting pressure on pharmaceutical companies to expedite the introduction of new drugs to the market, outsourcing emerges as a solution to accelerate the drug development process. Leveraging their expertise, experience, and cutting-edge equipment, CDMOs facilitate the swift & efficient production of high-quality drugs, enabling pharmaceutical firms to adhere to their development schedules. In addition, several pharmaceutical companies prefer CDMOs to access advanced infrastructure and expertise due to the increasing influx of novel therapies & orphan drugs and higher returns on approved products. Moreover, continuous technological advancements among CDMOs offer innovative small molecule APIs to meet the growing demands for innovation, efficiency, and regulatory compliance in the healthcare industry.

The adoption of advanced technologies by companies enhances drug development, manufacturing processes, and productivity. The increasing demand for new small molecule innovator API in the pharmaceutical industry is encouraging commercial CDMOs to expand their capabilities, which is expected to boost market growth. For instance, in August 2023, Astex announced a research collaboration & license agreement with MSD to classify small molecule candidates with tumor suppressor proteins for cancer treatment. Under the agreement, the company will use its fragment-based drug discovery platform to develop compounds and provide MSD with main compounds for preclinical development & optimization.

Small Molecule Innovator API CDMO Market Report Highlights

  • The clinical stage type segment led the small molecule innovator API CDMO industry and accounted for 54.56% of global revenue in 2024. The preclinical segment is anticipated to grow at a lucrative CAGR over the forecast period.
  • The pharmaceutical segment dominated the market in 2024, accounting for a revenue share of 91.07%. Small-molecule drugs have been the backbone of the pharmaceutical industry for nearly a century. The biotechnology segment's expansion is driven by rising demand for biotechnology and enhanced molecular efficiency.
  • The oncology segment dominated the small molecule innovator API CDMO market in 2024 and is expected to grow at the fastest CAGR of 6.80% during the forecast period. The infectious diseases market has witnessed dynamic trends and scenarios across various disease segments.
  • North America small molecule innovator API CDMO market is expected to grow at a CAGR of 5.91% over the forecast period. Asia Pacific held the largest market share of 41.74% in 2024.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This Report Addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Stage Type
1.2.2. Customer Type
1.2.3. Therapeutic Area
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Small Molecule Innovator API CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Demand for Small Molecule Drugs
3.2.1.2. Increasing Outsourcing Trends Among Pharmaceutical Companies
3.2.1.3. Surge In Number of Clinical Trials
3.2.2. Market Restraint Analysis
3.2.2.1. Compliance Issues While Outsourcing
3.2.2.2. Changing Scenarios in Developing Economies
3.3. Technological Landscape
3.3.1. Integration of AI in Small Molecule Innovator API CDMO Market
3.3.1.1. Current Dynamics and Future Trends
3.3.1.1.1. Drug Discovery and Design
3.3.1.1.2. AI-Assisted Drug API Synthesis
3.3.1.1.3. Process Optimization
3.3.1.1.4. Supply Chain Management
3.3.1.1.5. Clinical Trial Optimization
3.3.1.1.6. Regulatory Compliance
3.4. Total Number of Clinical Trials by Phase & Region (2021 - 2024)
3.4.1. Total Number of Clinical Trials by Phase (2021 - 2024)
3.4.2. Total Number of Clinical Trials by Region (2021 - 2024)
3.4.2.1. Percentage of Clinical Trials by Major Countries in North America:
3.4.2.2. Percentage of Clinical Trials by Major Countries in Europe:
3.4.2.3. Percentage of Clinical Trials by Major Countries in Asia Pacific:
3.4.2.4. Percentage of Clinical Trials by Major Countries in Latin America:
3.4.2.5. Percentage of Clinical Trials by Major Countries in the Middle East & Africa:
3.4.2.6. Total Number of Clinical Trials by Therapeutic Area (2021 - 2024)
3.5. Pricing Model Analysis
3.6. Market Analysis Tools
3.6.1. Porter’s Five Analysis
3.6.2. PESTEL by SWOT Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Small Molecule Innovator API CDMO Market: Stage Type Estimates & Trend Analysis
4.1. Small Molecule Innovator API CDMO Market, By Stage Type: Segment Dashboard
4.2. Small Molecule Innovator API CDMO Market, By Stage Type: Movement Analysis
4.3. Small Molecule Innovator API CDMO Market Estimates & Forecasts, By Stage Type, 2018 - 2030
4.4. Preclinical
4.4.1. Preclinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Clinical
4.5.1. Clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Phase I
4.5.2.1. Phase I Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Phase II
4.5.3.1. Phase II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Phase III
4.5.4.1. Phase III Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Commercial
4.6.1. Commercial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Small Molecule Innovator API CDMO Market: Customer Type Estimates & Trend Analysis
5.1. Small Molecule Innovator API CDMO Market, By Customer Type: Segment Dashboard
5.2. Small Molecule Innovator API CDMO Market, By Customer Type: Movement Analysis
5.3. Small Molecule Innovator API CDMO Market Estimates & Forecasts, By Customer Type, 2018 - 2030
5.4. Pharmaceutical
5.4.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Small
5.4.2.1. Small Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Medium
5.4.3.1. Medium Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Large
5.4.4.1. Large Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Biotechnology
5.5.1. Biotechnology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Small
5.5.2.1. Small Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Medium
5.5.3.1. Medium Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.4. Large
5.5.4.1. Large Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Small Molecule Innovator API CDMO Market: Therapeutic Area Estimates & Trend Analysis
6.1. Small Molecule Innovator API CDMO Market, By Therapeutic Area: Segment Dashboard
6.2. Small Molecule Innovator API CDMO Market, By Therapeutic Area: Movement Analysis
6.3. Small Molecule Innovator API CDMO Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030
6.4. Cardiovascular Diseases
6.4.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Oncology
6.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Respiratory Disorders
6.6.1. Respiratory Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Neurology
6.7.1. Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Metabolic Disorders
6.8.1. Metabolic Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Infectious Diseases
6.9.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Small Molecule Innovator API CDMO Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. China
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Japan
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.8. Taiwan
7.6.8.1. Key Country Dynamics
7.6.8.2. Competitive Scenario
7.6.8.3. Regulatory Framework
7.6.8.4. Taiwan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.6. Israel
7.8.6.1. Key Country Dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory Framework
7.8.6.4. Israel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Market Position Analysis, 2024 (Heat Map Analysis)
8.3. Company Profiles
8.3.1. Lonza Group Ltd.
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Novo Holdings (Catalent, Inc.)
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Thermo Fisher Scientific, Inc.
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Siegfried Holding AG
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Recipharm AB
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. CordenPharma International
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Samsung Biologics
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Labcorp
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Ajinomoto Bio-Pharma Services
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Piramal Pharma Solutions
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Jubilant Life Sciences (Jubilant Biosys Limited)
8.3.11.1. Company Overview
8.3.11.2. Financial Performance
8.3.11.3. Service Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. WuXi AppTec Co., Ltd.
8.3.12.1. Company Overview
8.3.12.2. Financial Performance
8.3.12.3. Service Benchmarking
8.3.12.4. Strategic Initiatives
List of Tables
Table 1 List of Tables
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 Global Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 5 Global Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 6 Global Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 7 Global Small Molecule Innovator API CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 8 North America Small Molecule Innovator API CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 9 North America Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 10 North America Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 11 North America Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 12 U.S. Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 13 U.S. Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 14 U.S. Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 15 Canada Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 16 Canada Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 17 Canada Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 18 Mexico Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 19 Mexico Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 20 Mexico Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 21 Europe Small Molecule Innovator API CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 22 Europe Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 23 Europe Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 24 Europe Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 25 UK Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 26 UK Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 27 UK Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 28 Germany Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 29 Germany Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 30 Germany Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 31 France Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 32 France Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 33 France Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 34 Italy Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 35 Italy Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 36 Italy Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 37 Spain Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 38 Spain Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 39 Spain Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 40 Denmark Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 41 Denmark Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 42 Denmark Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 43 Sweden Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 44 Sweden Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 45 Sweden Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 46 Norway Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 47 Norway Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 48 Norway Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Small Molecule Innovator API CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 52 Asia Pacific Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 53 China Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 54 China Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 55 China Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 56 Japan Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 57 Japan Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 58 Japan Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 59 India Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 60 India Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 61 India Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 62 Australia Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 63 Australia Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 64 Australia Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 65 South Korea Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 66 South Korea Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 67 South Korea Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 68 Thailand Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 69 Thailand Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 70 Thailand Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 71 Taiwan Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 72 Taiwan Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 73 Taiwan Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 74 Latin America Small Molecule Innovator API CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 75 Latin America Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 76 Latin America Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 77 Latin America Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 78 Brazil Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 79 Brazil Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 80 Brazil Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 81 Argentina Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 82 Argentina Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 83 Argentina Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Small Molecule Innovator API CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 85 Middle East & Africa Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 86 Middle East & Africa Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 87 Middle East & Africa Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 88 South Africa Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 89 South Africa Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 90 South Africa Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 92 Saudi Arabia Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 93 Saudi Arabia Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 94 UAE Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 95 UAE Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 96 UAE Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 97 Kuwait Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 98 Kuwait Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 99 Kuwait Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 100 Israel Small Molecule Innovator API CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 101 Israel Small Molecule Innovator API CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 102 Israel Small Molecule Innovator API CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Small molecule innovator API CDMO market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-Chain-Based Sizing & Forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Segment snapshot 1
Fig. 13 Segment snapshot 2
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent market outlook, 2024 (USD Million)
Fig. 16 Ancillary market outlook, 2024 (USD Million)
Fig. 17 Small Molecule Innovator API CDMO Market Dynamics
Fig. 18 Percentage of clinical trials by major countries in North America
Fig. 19 Percentage of clinical trials by major countries in Europe
Fig. 20 Percentage of clinical trials by major countries in Asia Pacific
Fig. 21 Percentage of clinical trials by major countries in Latin America
Fig. 22 Percentage of clinical trials by major countries in Middle East & Africa
Fig. 23 Porter’s five forces analysis
Fig. 24 Small molecule innovator API CDMO market: PESTEL analysis
Fig. 25 Small Molecule Innovator API CDMO Market: Stage Type outlook and key takeaways
Fig. 26 Small Molecule Innovator API CDMO Market: Stage Type movement analysis
Fig. 27 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Commercial market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Small Molecule Innovator API CDMO Market: Customer Type outlook and key takeaways
Fig. 34 Small Molecule Innovator API CDMO Market: Customer Type movement analysis
Fig. 35 Pharmaceutical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Small market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Medium market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Large market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Biotechnology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Small market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Medium market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Large market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Small Molecule Innovator API CDMO Market: Therapeutic Area outlook and key takeaways
Fig. 44 Small Molecule Innovator API CDMO Market: Therapeutic Area movement analysis
Fig. 45 Cardiovascular Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Respiratory Disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Metabolic Disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Regional Marketplace: Key Takeaways
Fig. 53 North America Small Molecule Innovator API CDMO Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 U.S. Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Canada Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Mexico Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Europe Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 UK Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Germany Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 France Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Italy Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Spain Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Denmark outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Sweden outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Norway outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Asia Pacific Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 China Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Japan Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 India Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Australia Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 South Korea Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Thailand Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Taiwan Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Latin America Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Brazil Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Argentina Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 MEA Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 South Africa Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Fig. Key country dynamics
Fig. 101 Saudi Arabia Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 UAE Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Key country dynamics
Fig. 105 Kuwait Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Key country dynamics
Fig. 107 Israel Small Molecule Innovator API CDMO Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 Key company categorization
Fig. 109 Service heat map analysis
Fig. 110 Strategic framework

Companies Mentioned

  • Lonza Group Ltd.
  • Novo Holdings (Catalent, Inc.)
  • Thermo Fisher Scientific, Inc.
  • Siegfried Holding AG
  • Recipharm AB
  • CordenPharma International
  • Samsung Biologics
  • Labcorp
  • Ajinomoto Bio-Pharma Services
  • Piramal Pharma Solutions
  • Jubilant Life Sciences (Jubilant Biosys Limited)
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 32.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 47.14 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Small Molecule Innovator API CDMO Market - Product Image

Small Molecule Innovator API CDMO Market

  • Report
  • 200 Pages
  • Global
From
Small Molecule Innovator CDMO Market Report 2025 - Product Image

Small Molecule Innovator CDMO Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Small Molecule Innovator CDMO Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Small Molecule Innovator CDMO Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Small Molecule CMO/CDMO Market Report 2025 - Product Image

Small Molecule CMO/CDMO Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Small Molecule Innovator API CDMO Market

In the pharmaceutical industry, the Small Molecule Innovator Active Pharmaceutical Ingredient (API) Contract Development and Manufacturing Organization (CDMO) market encompasses a network of companies that provide a wide array of services for the development, manufacturing, and commercialization of small molecule APIs. Small molecules, traditionally the cornerstone of pharmaceutical offerings, are organic compounds with low molecular weight that can easily enter cells and alter biological processes. The Small Molecule API CDMOs offer expertise in chemistry, helping innovator companies to accelerate the drug development pipeline from initial conception through clinical trials to market launch. These services are pivotal for pharmaceutical companies that lack the requisite infrastructure or choose to outsource these functions to focus on core competencies such as drug discovery and marketing. The CDMO market is characterized by its versatile array of technologies, including custom synthesis, process optimization, scale-up, and regulatory compliance designed to meet the bespoke needs of innovator companies. Several prominent companies are operating within the Small Molecule Innovator API CDMO market, including Catalent, Lonza Group, Patheon (part of Thermo Fisher Scientific), Siegfried Holding AG, Cambrex Corporation, Wuxi AppTec, and Piramal Pharma Solutions. These organizations have established reputations for their technical capabilities, compliance track records, and supply chain reliability, making them vital partners in the pharmaceutical manufacturing landscape. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.